Medisch Spectrum Twente — Clinical Trial Site

106 Registered trials

53 Currently recruiting

Organisation

Medisch Spectrum Twente

Location

Enschede, Netherlands

Identifier

ORG-100043548

Address

Koningsplein 1, 7512 KZ, Netherlands

Departments

#2923:Cardiology
#3704: Cardiology
2603: Cardiology
5002: Cardiology
Afd. Interne geneeskunde
Anesthesiology
Cardiology
chirurgie
Department E25 Oncology/ internal medicine
Department of Surgery
gastroenterology
Gastroenterology and Hepatology
Gynaecologic Oncology
Gynaecology
Haematology
Hematologie
Hematology
Hematology / Internal medicine
Hematology, Internal medicine
HPB surgery
ICU
Intensive care
Intensive Care Centrum
Internal Medicine
Internal medicine/haematology/oncology
interne geneeskunde
Kindergeneeskunde
Longgeneeskunde
Medical Oncology
medische oncologie
N/A
NA
Neurologie
Neurology
Neurosurgery
Obstetrics & Gynaeccology
Oncologie
Oncology
Otorhinolaryngology
pharmacy
Pulmonary Diseases
Pulmonary medicine
Pulmonary Science
Pulmonology
Research Faculty
Respiratory Deparment
Reumatologie
Rheumatology
Surgery
Thorax centrum Twente
Thoraxcentrum Twente

Clinical trials at this site (106)

Search interface

SAFEST Not authorised

2022-502059-79-00 Ischemic stroke or transient ischemic attack 6
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
Avelumab Short Maintenance Trial Pending

2024-512975-11-01 urothelial cancer 11
Filgotinib bridging in newly diagnosed rheumatoid arthritis patients (FAST RA trial); A pragmatic randomized controlled non-inferiority low … Pending

2024-517112-30-00 Rheumatoid arthritis 6
Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an… Pending

2025-524229-41-00 Triple negative breast cancer 5
HO182 CLL: Treatment of patients with chronic lymphocytic leukemia (CLL) with 6 cycles of rituximab in combination with 6 or 26 cycles of ve… Pending

2025-524283-38-00 Relapsed or refractory chronic lymphocytic leukemia 5
An International, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Trial on the Effects of EA-230 on the Length of Hospit… Pending

2025-525053-39-00 Coronary artery disease 5
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1) Recruiting

2025-521950-41-00 severe uncontrolled asthma 5 2026-06-05
Study for frail patients with newly diagnosed multiple myeloma treated with Daratumumab in combination with Teclistamab and Talquetamab. Recruiting

2024-520433-76-00 Newly Diagnosed Multiple Myeloma 4 2026-01-08
ASPIRING Recruiting

2024-516188-10-00 Intracerebral haemorrhage 6 2025-10-07
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 3 Protocol to Assess the Efficacy and Safety of Nipocalimab in Adults with… Recruiting

2024-513965-38-01 Sjögren's Disease 5 2025-06-16
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
The QUEEN-IVF trial: Quinidine versus verapamil in short-coupled idiopathic ventricular fibrillation: An open-label, randomized crossover pi… Recruiting

2024-511190-30-00 Short-coupled Idiopathic Ventricular Fibrillation 4 2024-11-25
Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study Recruiting

2024-510617-15-00 Non-metastatic resectable pancreatic cancer 5 2024-09-06
A Phase 3 program evaluating the effect of filgotinib in subjects with active axial spondyloarthritis Recruiting

2022-501354-10-01 axial spondyloarthritis 5 2023-06-21
This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting

2023-505277-32-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2023-01-26
PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer Recruiting

2025-522883-34-00 Metastatic cervical cancer 6 2026-06-12
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Recruiting

2023-506194-35-00 Colorectal liver metastases 5 2026-05-22
eValuating the efficacy and safety of InitiatinG depemokImab earLy therApy iN COPD with Type 2 inflammation (VIGILANT) Recruiting

2025-521108-23-00 Chronic Obstructive Pulmonary Disease 5 2026-05-19
Clinical Surveillance vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism: A Multicenter Randomized Plac… Recruiting

2023-507801-32-00 Isolated Subsegmental Pulmonary Embolism 6 2026-04-22
A study to learn about how safe BAY 3389934 is, its suitable dose, and how it affects the participants with sepsis and coagulopathy Recruiting

2024-515635-30-00 Coagulopathy 3 2026-03-24
Lp(a) lowering study of pelacarsen (TQJ230) with background inclisiran in participants with elevated Lp(a) and established ASCVD Recruiting

2024-516356-18-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-02-17
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Platinum Resistant Ovarian Cancer Recruiting

2024-514822-21-00 Platinum-resistant Ovarian Cancer 5 2025-10-02